Business View Magazine | February 2019

337 up money that sits in trust with a lawyer, then gets released when you go on the U.S. Stock Exchange from the RPOs.That happened on April 20, 2018 –two years to the day from our incorporation date on April 20, 2016. So lot’s of good karma on 4/20.” (April 20th or 4/20 has become an international holiday,where people gather to celebrate and smoke cannabis). BVM: What types of products are you developing? Goldstein: “We’ve been trading for several months now, building the business, and we have a deal in place for part of our product line with Emblem Corp., a licensed producer in Paris,Ontario.We’ve completed a series of batches there that have been, and are being, tested by third parties with the end goal to submit a file to Health Canada to have our tablets approved as the next best oral dose delivery mechanism. Beyond that we do immediate release, flash belt, extended release, and a bi-layer tablet which will be really cool. It will allow us to have an instant release,THC-based portion of the tablet to give the euphoric feeling, some initial pain relief, and perhaps a better sleep.Then, on the extended release portion of the pill,we add in CBD oil with extended release capabilities, so the person wakes up feeling good.Not hung over at all.” Garfinkle Biderman is a cohesive, efficient and forward-thinking law firm. We are experts at navigating the legal system, leveraging relationships and negotiating to win. • Commercial Real Estate • Land and Condominium Development • Commercial Lending • Conflict Resolution Services • Bankruptcy, Insolvency and Restructuring • Employment • Corporate and Commercial • Corporate Finance and Securities • Tax and Estate Planning • Mergers and Acquisitions • Franchising 1 Adelaide Street East, Suite 801, Toronto, Ontario, Canada M5C 2V9 Ph: 416-869-1234 | Fax: 416-869-0547 | www.garfinkle.com AT A GLANCE CANNTAB THERAPEUTICS WHAT: A cannabis technology company WHERE: Cobourg, Ontario, Canada WEBSITE: www.canntab.ca